| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcus Biosciences, Inc. | Chief Medical Officer | Common Stock | 20.7K | $414K | $20.00 | Jun 17, 2021 | Direct |
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 45K | Jul 8, 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 22.5K | Jun 2, 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Restricted Stock Unit (RSU) | 15K | Jun 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ENGN | enGene Holdings Inc. | Jul 8, 2025 | 1 | $0 | 4 | Jul 10, 2025 | Director |
| ENGN | enGene Holdings Inc. | Jul 8, 2025 | 0 | $0 | 3 | Jul 8, 2025 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jun 2, 2025 | 2 | $0 | 4 | Jun 4, 2025 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jan 17, 2024 | 1 | $0 | 4 | Jan 19, 2024 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jan 17, 2024 | 0 | $0 | 3 | Jan 19, 2024 | Director |
| RCUS | Arcus Biosciences, Inc. | Jun 16, 2021 | 3 | -$169K | 4 | Jun 21, 2021 | Chief Medical Officer |